Local nasal immunotherapy is a safe alternative immunotherapy route that improves clinical symptoms, reduces medication usage, and increases the nasal provocation threshold.
What’s New in Immunotherapy?
How to Safely Re-engage Allergy Immunotherapy Patients after Coronavirus Shutdown
Otolaryngology practices these practices need to consider how best to re-engage their allergy immunotherapy patients, including answering: Which services to start with? Which patients? Which procedures?
A Look at Immunotherapy’s Potential for Head and Neck Cancer Treatment
Experts at the AAO-HNS Annual Meeting in Atlanta discuss checkpoint inhibitor success and ways to overcome resistance.
The Role of Checkpoint Inhibitors in the Treatment of Head and Neck Cancer
Immunotherapy Benefits for Treating Allergic Rhinitis
Research finds patients with seasonal allergies not well controlled by medication can be offered sublingual tablet immunotherapy
Update on Diagnosis and Management of Food Allergies
With the rising prevalence of food allergies and their associated potentially fatal consequences, understanding the pathophysiology of food allergies along with their diagnosis and treatment remains a critical part of otolaryngologic practice.
Former AAOA Heads Take on Allergic Rhinitis
An expert panel containing three former American Academy of Otolaryngic Allergy presidents recently provided a look at the future of allergic rhinitis, as well as a refresher on how best to treat it.
First Two Patients Respond to Gene Therapy in Melanoma Study
Gene therapy as a treatment for cancer has advanced from the theoretical to the possible: in a pilot study published in August in the journal Science, investigators reported that two of 17 patients with advanced melanoma responded to a treatment known as genetically engineered therapy.
Proposed Vial Mixing Standard May Have Adverse Effects for Otolaryngologists
Standards proposed by the United States Pharmacopeia (USP) for the compounding of sterile medication could be applied to vial mixing in the office.